Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 18;11(14):4159.
doi: 10.3390/jcm11144159.

Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost

Affiliations

Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost

Elena Nutterova et al. J Clin Med. .

Abstract

The aim of the study was to compare the treatment of hypertensive glaucoma (HTG) in the early stages with carteolol and latanoprost by assessing the change in vessel density (VD) and retinal nerve fibre layer (RNFL). Methods: The first group with diagnosed HTG consisted of 46 eyes treated with carteolol; the second group consisted of 52 eyes treated with latanoprost. The following examinations were evaluated in all patients: intraocular pressure (IOP), retinal nerve fibre layer (RNFL), vessel density (VD) and visual field examination (glaucoma fast threshold test). The results were compared before treatment and 3 months after treatment. Results: There was no difference in the overall visual field defect (OD) between groups before treatment. After treatment, there was a decrease in IOP in both groups (carteolol-treated group had a mean decrease of 5.8 mmHg and latanoprost-treated eyes had a mean decrease of 7 mmHg). This difference was not statistically significant (p = 0.133). No similar difference was observed for RNFL (p = 0.161). In contrast, the change in the VD parameter was statistically significant between groups (p < 0.05), with a greater difference observed in the carteolol-treated group of eyes. Carteolol had a better effect on the VD.

Keywords: OCTA; RNFL; hypertensive glaucoma; treatment with carteolol and latanoprost; vessel density.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of the density of blood vessels in the patient’s right eye from October 2021 (upper part) and May 2022 (lower part).

Similar articles

Cited by

References

    1. Kang J.M., Tanna A.P. Glaucoma. Med. Clin. North Am. 2021;105:493–510. doi: 10.1016/j.mcna.2021.01.004. - DOI - PubMed
    1. Shen J., Wang Y., Yao K. Protection of retinal ganglion cells in glaucoma: Current status and future. Exp. Eye Res. 2021;205:108506. doi: 10.1016/j.exer.2021.108506. - DOI - PubMed
    1. Cvenkel B., Kolko M. Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment. J. Ophthalmol. 2020;2020:6138132. doi: 10.1155/2020/6138132. - DOI - PMC - PubMed
    1. Lee D.A., Higginbotham E.J. Glaucoma and its treatment: A review. Am. J. Health Syst. Pharm. 2005;62:691–699. doi: 10.1093/ajhp/62.7.691. - DOI - PubMed
    1. Hoyng P.F., van Beek L.M. Pharmacological therapy for glaucoma: A review. Drugs. 2000;59:411–434. doi: 10.2165/00003495-200059030-00003. - DOI - PubMed

LinkOut - more resources